Treatment and Clinical Outcomes of Transcatheter Heart Valve Thrombosis

Circulation: Cardiovascular Interventions

Volumn 8, Issue 4, 2015, Pages

  Latib, Azeem ^a,b   Naganuma, Toru ^a,b   Abdel Wahab, Mohamed ^c   Danenberg, Haim ^d   Cota, Linda ^e   Barbanti, Marco ^f   Baumgartner, Helmut ^g   Finkelstein, Ariel ^h   LeGrand, Victor ⁱ   De Lezo, José Suárez ^j   Kefer, Joelle ^k   Messika Zeitoun, David ^l   Richardt, Gert ^c   Stabile, Eugenio ^e   Kaleschke, Gerrit ^g   Vahanian, Alec ^l   Laborde, Jean Claude ^m   Leon, Martin B ⁿ   Webb, John G ^f   Panoulas, Vasileios F ^a,b   Maisano, Francesco ^a   Alfieri, Ottavio ^a   Colombo, Antonio ^a,b   more..

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^c Segeberger Kliniken GmbH   (Germany)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e Clinica Montevergine   (Italy)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^h TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

ⁱ UNIVERSITY OF LIÈGE   (Belgium)

^j HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^k CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^l BICHAT HOSPITAL   (France)

^m ST GEORGE S HOSPITAL   (United Kingdom)

ⁿ NewYork Presbyterian Hospital   (United States)

more..

Author keywords

anticoagulants; aortic valve stenosis; bioprosthesis; echocardiography; thrombosis; transcatheter aortic valve replacement

Indexed keywords

ANTIVITAMIN K; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT;

AGED; ANTICOAGULANT THERAPY; AORTA VALVE REPLACEMENT; AORTIC VALVE PRESSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; GENERAL CONDITION DETERIORATION; HEART VENTRICLE PRESSURE; HEPARINIZATION; HISTOPATHOLOGY; HUMAN; INTERVENTION STUDY; MALE; MITRAL VALVE DISEASE; MITRAL VALVE STENOSIS; PERCUTANEOUS AORTIC VALVE; PRIORITY JOURNAL; PROGNOSIS; PROSTHETIC VALVE THROMBOSIS; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; TREATMENT RESPONSE; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; ITALY; MULTICENTER STUDY; POSTOPERATIVE COMPLICATIONS; PREVALENCE; THROMBOSIS; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; ITALY; MALE; POSTOPERATIVE COMPLICATIONS; PREVALENCE; THROMBOSIS; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84937401574     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.114.001779     Document Type: Article

References (28)

1. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB; PARTNER Trial Investigators. Transcatheter aorticvalve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696-1704. Doi: 10. 1056/NEJMoa1202277.
2. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-1695. Doi: 10. 1056/NEJMoa1200384.
3. Godino C, Maisano F, Montorfano M, Latib A, Chieffo A, Michev I, Al-Lamee R, Bande M, Mussardo M, Arioli F, Ielasi A, Cioni M, Taramasso M, Arendar I, Grimaldi A, Spagnolo P, Zangrillo A, La Canna G, Alfieri O, Colombo A. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. JACC Cardiovasc Interv. 2010;3:1110-1121. Doi: 1016/j. jcin. 2010. 09. 012.
4. Toggweiler S, Humphries KH, Lee M, Binder RK, Moss RR, Freeman M, Ye J, Cheung A, Wood DA, Webb JG. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol. 2013;61:413-419. Doi: 10. 1016/j. jacc. 2012. 11. 010.
5. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299-308. Doi: 10. 1161/CIRCULATIONAHA. 110. 946533.
6. Holmes DR Jr, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, Calhoon JH, Carabello BA, Desai MY, Edwards FH, Francis GS, Gardner TJ, Kappetein AP, Linderbaum JA, Mukherjee C, Mukherjee D, Otto CM, Ruiz CE, Sacco RL, Smith D, Thomas JD, Harrington RA, Bhatt DL, Ferrari VA, Fisher JD, Garcia MJ, Gardner TJ, Gentile F, Gilson MF, Hernandez AF, Jacobs AK, Kaul S, Linderbaum JA, Moliterno DJ, Weitz HH; American Heart Association; American Society of Echocardiography; European Association for Cardio-Thoracic Surgery; Heart Failure Society of America; Mended Hearts; Society of Cardiovascular Anesthesiologists; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Thorac Cardiovasc Surg. 2012;144:e29-e84. Doi: 10. 1016/j. jtcvs. 2012. 03. 001.
7. Brennan JM, Edwards FH, Zhao Y, O'Brien S, Booth ME, Dokholyan RS, Douglas PS, Peterson ED; DEcIDE AVR Research Team. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. J Am Coll Cardiol. 2012;60:971-977. Doi: 10. 1016/j. jacc. 2012. 05. 029.
8. Puvimanasinghe JP, Steyerberg EW, Takkenberg JJ, Eijkemans MJ, van Herwerden LA, Bogers AJ, Habbema JD. Prognosis after aortic valve replacement with a bioprosthesis: predictions based on meta-analysis and microsimulation. Circulation. 2001;103:1535-1541.
9. Brown ML, Park SJ, Sundt TM, Schaff HV. Early thrombosis risk in patients with biologic valves in the aortic position. J Thorac Cardiovasc Surg. 2012;144:108-111. Doi: 10. 1016/j. jtcvs. 2011. 05. 032.
10. El Bardissi AW, Di Bardino DJ, Chen FY, Yamashita MH, Cohn LH. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm? J Thorac Cardiovasc Surg. 2010;139:1137-1145. Doi: 10. 1016/j. jtcvs. 2009. 10. 064.
11. Stassano P, Di Tommaso L, Monaco M, Iorio F, Pepino P, Spampinato N, Vosa C. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years. J Am Coll Cardiol. 2009;54:1862-1868. Doi: 10. 1016/j. jacc. 2009. 07. 032.
12. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36:1152-1158.
13. Latib A, Messika-Zeitoun D, Maisano F, Himbert D, Agricola E, Brochet E, Alfieri O, Colombo A, Vahanian A. Reversible Edwards Sapien XT dysfunction due to prosthesis thrombosis presenting as early structural deterioration. J Am Coll Cardiol. 2013;61:787-789. Doi: 10. 1016/j. jacc. 2012. 10. 016.
14. Kefer J, Astarci P, Renkin J, Glineur D, Pierard S, Seldrum S, Vanoverschelde JL. Images and case reports in interventional cardiology. Thrombotic aortic restenosis after transapical Sapien valve implantation. Circ Cardiovasc Interv. 2010;3:289-292. Doi: 10. 1161/ CIRCINTERVENTIONS. 109. 935031.
15. Cota L, Stabile E, Agrusta M, Sorropago G, Pucciarelli A, Ambrosini V, Mottola G, Esposito G, Rubino P. Bioprostheses "thrombosis" after transcatheter aortic valve replacement. J Am Coll Cardiol. 2013;61:789-791. Doi: 10. 1016/j. jacc. 2012. 11. 042.
16. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57:253-269. Doi: 10. 1016/j. jacc. 2010. 12. 005.
17. Généreux P, Head SJ, Van Mieghem NM, Kodali S, Kirtane AJ, Xu K, Smith C, Serruys PW, Kappetein AP, Leon MB. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions. J Am Coll Cardiol. 2012;59:2317-2326. Doi: 1016/j. jacc. 2012. 02. 022.
18. Buchanan GL, Chieffo A, Montorfano M, Maisano F, Latib A, Godino C, Cioni M, Gullace MA, Franco A, Gerli C, Alfieri O, Colombo A. The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN™ and Medtronic CoreValve ReValving System® devices: the Milan registry. EuroIntervention. 2011;7:556-563. Doi: 10. 4244/EIJV7I5A91.
19. Stähli BE, Bünzli R, Grünenfelder J, Bühler I, Felix C, Bettex D, Biaggi P, Tanner FC, Nguyen-Kim DL, Plass A, Ge H, Falk V, Lüscher TF, Corti R, Maier W, Altwegg LA. Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the Valve Academic Research Consortium (VARC). J Invasive Cardiol. 2011;23:307-312.
20. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198. Doi: 10. 1056/ NEJMoa1103510.
21. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607. Doi: 10. 1056/NEJMoa1008232.
22. Makkar RR, Jilaihawi H, Mack M, Chakravarty T, Cohen DJ, Cheng W, Fontana GP, Bavaria JE, Thourani VH, Herrmann HC, Pichard A, Kapadia S, Babaliaros V, Whisenant BK, Kodali SK, Williams M, Trento A, Smith CR, Teirstein PS, Cohen MG, Xu K, Tuzcu EM, Webb JG, Leon MB. Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons. J Am Coll Cardiol. 2014;63:901-911. Doi: 10. 1016/j. jacc. 2013. 08. 1641.
23. Lancellotti P, Radermecker MA, Weisz SH, Legrand V. Subacute transcatheter CoreValve thrombotic obstruction. Circ Cardiovasc Interv. 2013;6:e32-e33. Doi: 10. 1161/CIRCINTERVENTIONS. 113. 000213.
24. Head SJ, Mokhles MM, Osnabrugge RL, Pibarot P, Mack MJ, Takkenberg JJ, Bogers AJ, Kappetein AP. The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. Eur Heart J. 2012;33:1518-1529. Doi: 10. 1093/eurheartj/ehs003.
25. Jilaihawi H, Chin D, Spyt T, Jeilan M, Vasa-Nicotera M, Bence J, Logtens E, Kovac J. Prosthesis-patient mismatch after transcatheter aortic valve implantation with the Medtronic-Corevalve bioprosthesis. Eur Heart J. 2010;31:857-864. Doi: 10. 1093/eurheartj/ehp537.
26. Piazza N, de Jaegere P, Schultz C, Becker AE, Serruys PW, Anderson RH. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv. 2008;1:74-81. Doi: 10. 1161/CIRCINTERVENTIONS. 108. 780858.
27. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Lung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M; ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42:S1-S44. Doi: 10. 1093/ejcts/ezs455.
28. Collet JP, Montalescot G. Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field? EuroIntervention. 2013;9(suppl):S43-S47. Doi: 10. 4244/EIJV9SSA9